26 February 2013: Join presenter Dr. Robert Dellavalle as he speaks with Dr. John R. Stanley from the University of Pennsylvania about desmoglein as a target for pemphigus and other skin disease therapies, which has illuminated the pathophysiology of seemingly unrelated diseases.